Home/Rezq Bio/Nick Giannoukakis, PhD

NG

Nick Giannoukakis, PhD

CSO and Founder

Therapeutic Areas

Autoimmune Diseases Inflammatory Diseases Type 1 Diabetes

Rezq Bio Pipeline

Drug	Indication	Phase
RZQ-MC1	Early Onset Type 1 Diabetes	Phase 1B/2A
RZQ-MC2	Colitis/IBD	Preclinical
RZQ-CC1	Transplant/Implant Support	Preclinical
RZQ-MM*	Type 1 Diabetes	Preclinical

Leadership Team at Rezq Bio

Arjun Hattiangadi

CEO and Founder

Howard Foyt, MD, PhD

Doug Greene, MD

Elina Linetsky, PhD

VP of Process, Development and Manufacturing

View full Rezq Bio profile